Search results for "Droit"

showing 10 items of 4600 documents

Cautionnement. Exceptions opposables par la caution, Inobservation de l'obligation d'information annuelle du banquier (oui), Extinction de la créance…

1998

International audience; (Com. 22 avr. 1997, consorts Dame c/ Crédit agricole mutuel de la Manche et autres ; Com. 20 mai 1997, Mene c/ Caisse régionale de Crédit agricole mutuel du Sud-Ouest et Billioud, ès qual. ; Com. 28 janv. 1997, BNP c/ M. Astarita et autre)

Admission définitive[SHS.DROIT]Humanities and Social Sciences/LawRedressement et liquidation judiciaires[SHS.DROIT] Humanities and Social Sciences/LawCAUTIONNEMENTDéclaration des créancesOpposabilité des exceptions
researchProduct

Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changes

2000

Background: The use of a viscoelastic substance facilitates cataract surgery. Healon 5 is a new viscoelastic product with special rheological properties. We evaluated the postoperative effect of Viscoat and Healon5 on intraocular pressure (IOP), central corneal thickness (CCT), endothelial cell counts and laser flare. Methods: Forty-eight eyes of 48 patients undergoing routine phacoemulsification followed by foldable IOL implantation were enrolled. Either Healon5 or Viscoat was used according to a block- randomization scheme. The aspiration technique was standardized. IOP, CCT, endothelial cell counts and laser flare were compared pre- and postoperatively. Statistical analysis was performed…

AdultMaleIntraocular pressuremedicine.medical_specialtyRandomizationgenetic structuresmedicine.medical_treatmentEye diseaseCell CountIntraocular lensAqueous HumorPhotometryCellular and Molecular NeuroscienceLens Implantation IntraocularCorneaOphthalmologymedicineHumansProspective StudiesHyaluronic AcidIntraocular PressurePhacoemulsificationbusiness.industryChondroitin SulfatesEndothelium CornealPhacoemulsificationCataract surgerymedicine.diseaseeye diseasesSensory SystemsDrug CombinationsOphthalmologymedicine.anatomical_structureQuartileFemalesense organsbusinessChondroitinGraefe's Archive for Clinical and Experimental Ophthalmology
researchProduct

Extracellular matrix composition in COPD

2012

Extracellular matrix (ECM) composition has an important role in determining airway structure. We postulated that ECM lung composition of chronic obstructive pulmonary disease (COPD) patients differs from that observed in smoking and nonsmoking subjects without airflow obstruction. We determined the fractional areas of elastic fibres, type-I, -III and -IV collagen, versican, decorin, biglycan, lumican, fibronectin and tenascin in different compartments of the large and small airways and lung parenchyma in 26 COPD patients, 26 smokers without COPD and 16 nonsmoking control subjects. The fractional area of elastic fibres was higher in non-obstructed smokers than in COPD and nonsmoking controls…

AdultMalePulmonary and Respiratory MedicineLumicanPathologymedicine.medical_specialtyDecorinLumicanTenascinSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary Disease Chronic ObstructiveBiglycanParenchymamedicineHumansCOPDLungAgedCOPDLungbiologybusiness.industryBiglycanSmokingTenascinMiddle Agedrespiratory systemmedicine.diseaseImmunohistochemistryExtracellular MatrixFibronectinsRespiratory Function Testsrespiratory tract diseasesmedicine.anatomical_structureChondroitin Sulfate ProteoglycansKeratan SulfateCase-Control Studiesbiology.proteinVersicanFemaleCollagenDecorinbusiness
researchProduct

Franceschetti Hereditary Recurrent Corneal Erosion

2011

To describe new affected individuals of Franceschetti's original pedigree of hereditary recurrent erosion and to classify a unique entity called Franceschetti corneal dystrophy.Observational case series.Slit-lamp examination of 10 affected individuals was conducted. Biomicroscopic examinations were supplemented by peripheral corneal biopsy in 1 affected patient with corneal haze. Tissue was processed for light and electron microscopy and immunohistochemistry was performed. DNA analysis was carried out in 12 affected and 3 nonaffected family members.All affected individuals suffered from severe ocular pain in the first decade of life, attributable to recurrent corneal erosions. Six adult pat…

AdultMalemedicine.medical_specialtyBiopsyDNA Mutational AnalysisDermatan SulfateCorneal dystrophyCorneal OpacityCorneal erosionAntigens NeoplasmRecurrenceTransforming Growth Factor betaOphthalmologymedicineEye PainHumansChildAgedAged 80 and overCorneal Dystrophies HereditaryExtracellular Matrix Proteinsbusiness.industryCadherinsmedicine.diseaseImmunohistochemistryPedigreeRecurrent corneal erosionOphthalmologyClaudinsFemaleDecorinbusinessCell Adhesion MoleculesChondroitinBiomarkersAmerican Journal of Ophthalmology
researchProduct

Heterogeneity of Morquio disease.

1986

Further clinical heterogeneity of Morquio disease, mucopolysaccharidosis IV (MPS IV), is delineated by the observation of a 30-year-old man with unusually mild clinical manifestations. He is 156 cm tall, has comparatively mild skeletal abnormalities and fine corneal deposits. Keratosulfaturia is absent. N-Acetylgalactosamine-6-sulfate (GalNAc-6-S) sulfatase (E.C. 3.1.6.-) was markedly reduced in his fibroblasts. The residual enzyme activity exhibited a pH profile comparable to that of patients with the "classical" form of the disorder. From our observation and a review of the literature it is concluded that Morquio disease can be divided in several subgroups: besides the severe ("classical"…

AdultMalemedicine.medical_specialtyDiseaseMucopolysaccharidosis Type IVAInternal medicineGeneticsmedicineHumansGenetics (clinical)chemistry.chemical_classificationbiologybusiness.industrySulfataseGenetic VariationMucopolysaccharidosis IVFibroblastsHydrogen-Ion Concentrationbeta-GalactosidasePhenotypeEnzyme assayChondroitinsulfatasesEnzymeEndocrinologyPhenotypechemistrybiology.proteinMucopolysaccharidosis IVbusinessNeuraminidaseClinical genetics
researchProduct

Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial

2015

Objective: To report and discuss the multi-domain impact of elosulfase alfa, with focus on tertiary and composite endpoints, in the 24-week, randomized, double-blind, placebo-controlled phase 3 trial in patients with Morquio A syndrome (mucopolysaccharidosis IVA). Methods: Patients with Morquio A syndrome >= 5 aged years were randomized 1:1:1 to elosulfase alfa 2.0 mg/kg/week (qw; N = 58), elosulfase alfa 2.0 mg/kg/every other week (qow; N = 59), or placebo (N = 59) for 24 weeks. Primary and secondary efficacy measures were 6-minute walk test (6MWT; primary), 3-minute stair climb test (3-MSCT) and urinary keratan sulfate (KS). Safety was also evaluated. Tertiary efficacy measures included r…

Adultmedicine.medical_specialtyAdolescentIdursulfaseMucopolysaccharidosisEndocrinology Diabetes and MetabolismPlaceboBiochemistrylaw.inventionYoung Adultchemistry.chemical_compoundEndocrinologyDouble-Blind MethodRandomized controlled trialElosulfase alfalawSurveys and QuestionnairesInternal medicineActivities of Daily LivingmedicineGeneticsHumansEnzyme Replacement TherapyRespiratory functionYoung adultChildMolecular Biologybusiness.industryMucopolysaccharidosis IVMaximal Voluntary VentilationMiddle Agedmedicine.diseaseBody HeightChondroitinsulfatasesRespiratory Function TestsTreatment OutcomechemistryChild PreschoolPhysical therapyPopulation studybusinessmedicine.drugMolecular genetics and metabolism
researchProduct

Is intravesical instillation of hyaluronic acid and chondroitin sulfate useful in preventing recurrent bacterial cystitis? A multicenter case control…

2015

Abstract Objective Urinary tract infections (UTIs) are common in the female population and, over a lifetime, about half of women have at least one episode of UTI requiring antibiotic therapy. The aim of the current study was to compare two different strategies for preventing recurrent bacterial cystitis: intravesical instillation of hyaluronic acid (HA) plus chondroitin sulfate (CS), and antibiotic prophylaxis with sulfamethoxazole plus trimethoprim. Materials and methods This was a retrospective review of two different cohorts of women affected by recurrent bacterial cystitis. Cases (experimental group) were women who received intravesical instillations of a sterile solution of high concen…

Adultmedicine.medical_specialtyRecurrent bacterial cystitismedicine.drug_classUrinary systemCystitiAntibioticsUrinalysislcsh:Gynecology and obstetricsGastroenterologyantibioticsantibiotics; chondroitin sulfate; cystitis; hyaluronic acidchemistry.chemical_compoundAdjuvants ImmunologicRecurrenceInternal medicineObstetrics and GynaecologyHyaluronic acidCystitismedicineHumansChondroitin sulfateAntibiotic prophylaxisHyaluronic Acidlcsh:RG1-991antibiotics chondroitin sulfate cystitis hyaluronic acidchondroitin sulfateRetrospective StudiesDose-Response Relationship Drugbusiness.industrySulfamethoxazoleChondroitin SulfatesAntibioticObstetrics and GynecologySettore MED/40 - Ginecologia E OstetriciaTrimethoprimSurgeryAdministration IntravesicalInstillation DrugchemistryUrinary Tract InfectionsDrug Therapy CombinationFemalebusinessmedicine.drugFollow-Up StudiesTaiwanese journal of obstetricsgynecology
researchProduct

Réflexion sur les seuils d'âge en droit pénal de fond

2018

International audience

AgeSeuil[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/LawRESPONSABILITE PENALEComputingMilieux_MISCELLANEOUS
researchProduct

La créance de restitution d'une subvention de l'ANAH a pour fait générateur la décision de retrait prise par l'ANAH

2003

International audience; (Com. 13 mai 2003, pourvoi n° F 99-16.156, arrêt n° 787 FS-P, J.-L. Brenac c/ Agence nationale pour l'amélioration de l'habitat)

Agence pour l'amélioration de l'habitat[SHS.DROIT]Humanities and Social Sciences/LawPoursuite de l'activité[SHS.DROIT] Humanities and Social Sciences/LawREDRESSEMENT ET LIQUIDATION JUDICIAIRESPériode d'observationCréance prioritaire
researchProduct

Fait générateur d'une créance de restitution. La créance de restitution d'une subvention de l'ANAH prend naissance à la date de la décision de retrait

2006

International audience; (Cass. com., 7 févr. 2006, pourvoi n° 05-10.607, arrêt n° 159 F-D, Tiberghien ès qual. c/ ANAH)

Agence pour l'amélioration de l'habitat[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/LawPoursuite de l'activitéREDRESSEMENT ET LIQUIDATION JUDICIAIRESPériode d'observationCréance prioritaire
researchProduct